SC 13G/A: Mineralys Therapeutics, Inc.
Ticker: MLYS · Form: SC 13G/A · Filed: Nov 13, 2024 · CIK: 1933414
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Mineralys Therapeutics, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 917 words · 4 min read · ~3 pages · Grade level 10 · Accepted 2024-11-13 16:19:46
Key Financial Figures
- $0.0001 — me of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti
Filing Documents
- tm2426170d2_sc13ga.htm (SC 13G/A) — 41KB
- 0001104659-24-117724.txt ( ) — 43KB
(a)
Item 1(a). Name of Issuer Mineralys Therapeutics, Inc.
(b)
Item 1(b). Address of Issuer’s Principal Executive Offices 150 N. Radnor Chester Road, Suite F200 Radnor, PA 19087
(a)
Item 2(a). Name of Person Filing HBM Healthcare Investments (Cayman) Ltd.
(b)
Item 2(b). Address of Principal Business Office Governors Square 23 Lime Tree Bay Avenue PO Box 30852 Grand Cayman, KY1-1204, Cayman Islands
(c)
Item 2(c). Citizenship Cayman Islands, British West Indies
(d)
Item 2(d). Title of Class of Securities Common Stock, $0.0001 par value
(e)
Item 2(e). CUSIP No. 603170101 Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: Not Applicable Item 4. (a) Amount beneficially owned: 2,246,332 (1) (b) Percent of class: 4.5% (2) (c) Number of shares as to which the Reporting Person has: (i) Sole power to vote or to direct the vote: 2,246,332 (1) (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 2,246,332 (1) (iv) Shared power to dispose or to direct the disposition of: 0 CUSIP No: 603170101 SCHEDULE 13G Page 4 of 5 Pages Item 5. If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x . Item 6. Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company Not Applicable Item 8. Identification and Classification of Members of the Group Not Applicable Item 9. Notice of Dissolution of Group Not Applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11. (1) Voting and investment power over the shares held by HBM Healthcare Investments (Cayman) Ltd. is exercised by the board of directors of HBM Healthcare Inves
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct. Dated: November 13, 2024 HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD. By: /s/ Jean-Marc LeSieur Name: Jean-Marc LeSieur Title: Managing Director SIGNATURE PAGE TO SCHEDULE 13G AMENDMENT NO. 1 (MINERALYS THERAPEUTICS, INC.) Attention: Intentional misstatements or omissions of fact constitute federal violations (see 18 U.S.C. 1001).